Soni Medicare Ltd

Soni Medicare, a microcap company in the hospital and healthcare services industry, has seen a significant increase in its stock price, reaching a 52-week high of Rs.45.98 on November 13, 2024. The company's stock has outperformed the sector and is currently trading higher than its moving averages, indicating a positive trend. With a strong performance in the past year, Soni Medicare is a company to watch in the healthcare sector.

Soni Medicare, a microcap company in the hospital and healthcare services industry, has recently reached a 52-week high of Rs.44 on November 12, 2024. However, according to MarketsMOJO, the stock is currently rated as a 'Sell'. The stock has underperformed the sector today, but has shown a long-term upward trend and has outperformed the Sensex in the past year. Investors should closely monitor the stock's performance and seek professional advice before making any investment decisions.

Soni Medicare, a microcap company in the hospital and healthcare services industry, has reached a new 52-week high on November 7th, 2024. Despite underperforming the sector today, the stock has gained 62.92% in the past year, leading to a 'Sell' recommendation from MarketsMOJO. However, the industry has shown a positive trend and investors should conduct their own research before investing.

Soni Medicare, a microcap company in the healthcare industry, has reached a 52-week high of Rs. 42.1 on November 4th, 2024. Despite a 'Sell' call from MarketsMOJO, the stock has shown a positive trend in the past four days and is currently trading above its moving averages. With a 1-year performance of 52.13%, the company has outperformed the Sensex, showcasing its growth potential and potential as a promising investment opportunity in the healthcare sector.

Soni Medicare, a microcap company in the healthcare industry, has recently seen a surge in its stock price, reaching a 52-week high of Rs. 39.31 on October 31, 2024. The stock has outperformed the sector by 3.99% and has shown consecutive gains for the past 3 days. However, this is not a recommendation to buy or sell the stock, as its future performance is uncertain.

Soni Medicare, a microcap company in the hospital and healthcare services industry, has reached a new 52-week high on October 30, 2024. The stock has outperformed the sector by 4.66% and gained 8.55% in the last two days. It hit a high of Rs.37.72, a 5.01% increase, and is trading higher than all its moving averages. With a 1-year performance of 39.03%, Soni Medicare shows strong growth and potential in the market. MarketsMOJO has given a 'Sell' call, but this is not a recommendation and investors should monitor the company's future developments.

Soni Medicare, a microcap company in the hospital and healthcare services industry, has reached a new 52-week high on October 21, 2024. With a current price of Rs. 36.8 and a gain of 4.87%, the stock has been performing well in the market. It has also outperformed the Sensex in the past year, showcasing its strong growth potential. Investors should conduct thorough research before making any investment decisions.

Soni Medicare, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on August 26, 2024. The stock has been on an upward trend for the past 6 days, gaining 38.14%. Despite a 'Sell' call from MarketsMOJO, Soni Medicare's stock has outperformed the sector and shown impressive growth in the past year.

Soni Medicare, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on August 23, 2024. The stock is currently rated as a 'Sell' by MarketsMOJO. It has outperformed the sector by 8.87% and is trading higher than its moving averages. In the past year, the stock has shown a strong performance, reflecting the company's consistent efforts in the healthcare industry.

Soni Medicare, a microcap healthcare services company, reported a flat performance for the quarter ending June 2024 with a score of 0, an improvement from -6 in the last 3 months. Despite being a reliable player in the industry, MarketsMOJO has given a 'Strong Sell' call, possibly due to the company's size and market conditions. Investors and stakeholders should closely monitor the company's progress and decisions in the coming months.

Soni Medicare, a microcap healthcare services company, reported its financial results for the quarter ending March 2024. Despite a 'Sell' stock call from MarketsMOJO, the company has shown improvement in its overall score due to streamlining operations and cost-cutting measures. Investors should conduct their own research before investing, considering the company's long-term potential in the competitive healthcare market.

Soni Medicare, a microcap healthcare services company, reported a slight decrease in net sales and standalone net profit for the quarter ended September 2023. However, there was a significant increase compared to the same quarter last year. The company's operating profit and interest expenses also saw changes, but overall, its financial performance has been steady with promising growth potential.